Healthy Skepticism Library item: 8734
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
George T, Srinivasan S.
Does the TGN1412 trial disaster have lessons for clinical trials in India?
Natl Med J India 2006 Sep-Oct; 19:(5):283-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17203685&query_hl=18&itool=pubmed_DocSum
Abstract:
No abstract available.
Keywords:
MeSH Terms:
Antibodies, Monoclonal/adverse effects*
Antibodies, Monoclonal/therapeutic use
Clinical Trials, Phase I/adverse effects
Clinical Trials, Phase I/ethics*
Drug Approval/legislation & jurisprudence*
Drugs, Investigational*
Great Britain
Human Experimentation/ethics*
Humans
India
Internationality
Male
Multiple Organ Failure/chemically induced
Orphan Drug Production
Poverty
Safety
Social Values
Substances:
Antibodies, Monoclonal
Drugs, Investigational
monoclonal antibody TGN1412
